NASDAQ:PALI Palisade Bio Q2 2026 Earnings Results & Report $0.84 -0.09 (-9.24%) Closing price 04:00 PM EasternExtended Trading$0.86 +0.02 (+2.39%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Palisade Bio beat analyst earnings expectations and met on revenue in its Q2 2026 results, released August 10, 2026. The company reported EPS of -$0.05 versus the -$0.0522 consensus estimate, while revenue of $500 thousand matched the $500 thousand estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 10, 2026TimeAfter Market ClosesConference Call7:00 AM ET Palisade Bio EPS ResultsActual EPS-$0.05Consensus EPS -$0.0522Beat/MissBeat by +$0.0022One Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersPalisade Bio Revenue ResultsActual Revenue$500 thousandExpected Revenue$500 thousandBeat/MissMet ExpectationsYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Palisade Bio Q2 2026 Earnings FAQ Did Palisade Bio beat earnings estimates for Q2 2026? Palisade Bio (NASDAQ:PALI) reported earnings of -$0.05 per share for Q2 2026, beating the consensus estimate of -$0.0522. The report was announced on Monday, August 10, 2026. What was Palisade Bio's revenue for Q2 2026? Palisade Bio reported revenue of $500 thousand for Q2 2026, against a consensus estimate of $500 thousand. Palisade Bio Earnings HeadlinesFY2026 EPS Estimate for Palisade Bio Reduced by AnalystNovember 16, 2026 | americanbankingnews.comFY2026 EPS Forecast for Palisade Bio Reduced by AnalystNovember 15, 2026 | americanbankingnews.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 20 at 1:00 AM | Base Camp Trading (Ad)Palisade Bio (NASDAQ:PALI) Stock Gets Price Target Reduction from HC WainwrightNovember 14, 2026 | americanbankingnews.comPalisade Bio (NASDAQ:PALI) Stock Moved Down to Strong Sell by Wall Street ZenNovember 14, 2026 | americanbankingnews.comPalisade Bio Advances PALI-2108 Phase 2 Programs; Reports Q3 Results, Stock UpNovember 12, 2026 | rttnews.comSee More Palisade Bio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Palisade Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palisade Bio and other key companies, straight to your email. Email Address About Palisade BioPalisade Bio (NASDAQ:PALI) is a clinical-stage biopharmaceutical company developing therapies for gastrointestinal diseases, with a focus on oral treatments for inflammatory bowel conditions. Its pipeline includes PALI-2108, an investigational, gut-targeted PDE4 inhibitor being developed for ulcerative colitis and fibrostenotic Crohn’s disease. The company has also developed LB1148, an investigational serine protease inhibitor studied for its potential to support bowel function and reduce complications after abdominal surgery. Palisade Bio’s candidates are in clinical development and are not approved for commercial use.View Palisade Bio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.